Target intelligence / Profile preview

Transcription elongation factor A-like 8 (TCEAL8)

Target
TCEAL8
Molecular classification
Transcription factor, Nuclear phosphoprotein
01

Overview

Transcription elongation factor A-like 8 (TCEAL8) is a member of the transcription elongation factor A (SII)-like gene family, which encodes nuclear phosphoproteins containing TFA domains thought to modulate transcription in a promoter context-dependent manner. TCEAL family proteins may influence the transcriptional output of various genes and could be involved in integrating transcriptional regulation with physiological processes such as neuronal excitability. TCEAL8 undergoes significant N6-methyladenosine (m6A) modification in cancer (notably pancreatic cancer tissues), and its expression has been identified as a marker in malignant cells, possibly acting downstream of the RNA methyltransferase METTL3 pathway. There are currently no drugs known to interact directly with this protein, and its function as a therapeutic target remains unclear; it is primarily treated as a putative regulatory protein and possible biomarker, especially in cancer biology.

Other names
WEX3Transcription elongation factor S-II protein-like 8TCEA-like protein 8MGC45400TCAL8_HUMAN (Uniprot)transcription elongation factor A (SII)-like 8
02

Biological functions

Modulation of transcription in a promoter context-dependent mannerRegulation of gene expressionPossible coupling of the transcriptional machinery to cellular pathways that regulate neuronal excitability and plasticityPutative role in transcriptional regulation (inferred from homology, especially with TCEAL1)
03

Disease associations

Cancer (identified as a novel marker gene in pancreatic cancer, and as possibly involved in malignant transformation through m6A modification)Other (no other strong disease association currently documented, but differential expression in various tissue types and cancer is reported)
04

Biomarkers

High N6-methyladenosine (m6A) modification of TCEAL8 mRNA serves as a novel marker for pancreatic cancer (especially in cells with high METTL3 expression)

Beyond the preview

Go deeper on Transcription elongation factor A-like 8 (TCEAL8).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transcription elongation factor A-like 8 (TCEAL8).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call